BIO-CHEM(SH:603360) Zheng Quan Ri Bao·2025-04-25 07:43Core Viewpoint - Dalian Baiao Chemical Co., Ltd. reported a revenue of 1.312 billion yuan for 2024, marking a year-on-year increase of 23.09%, and a net profit of 345 million yuan, up 5.14% year-on-year. The company is strategically expanding into the semiconductor equipment business while consolidating its traditional industrial biocide operations [2][4]. Group 1: Financial Performance - The company achieved a revenue of 1.312 billion yuan in 2024, a 23.09% increase compared to the previous year [2]. - The net profit attributable to shareholders was 345 million yuan, reflecting a year-on-year growth of 5.14% [2]. - The industrial biocide business generated 1.207 billion yuan in revenue, up 14.49% year-on-year, with foreign revenue reaching 762 million yuan, a 26.20% increase [3]. Group 2: Business Segments - The industrial biocide segment, focusing on isothiazolinone-based products, has over 40,000 tons/year production capacity, making it the largest producer in Asia [3]. - The company has developed over 50 formulation products, with more than 30 currently on sale, aiming to enhance profit margins and market presence [3]. - The newly acquired semiconductor business generated revenue of 97.78 million yuan in 2024, with a gross margin of 43.38% [4]. Group 3: Strategic Initiatives - The company plans to distribute 4 shares for every 10 shares held and pay a cash dividend of 6 yuan per share [2]. - A share repurchase plan is in place, with a budget of 200 million to 400 million yuan to support employee stock ownership plans [2]. - The acquisition of Suzhou Xinhuilian Semiconductor Technology Co., Ltd. is expected to enhance the company's capabilities in the semiconductor sector, contributing to a dual-driven growth model of "chemicals + semiconductors" [5][6].